Abstract:

Join us for an insightful evening with Rod Ferguson, a venture capitalist at Panorama Capital. Dr. Ferguson will talk about medical advances and the future of venture capital.

Biography:

Dr. Ferguson is a co-founder of Panorama and focuses primarily on life sciences investments. He joined JPMorgan Partners in 2001. From 1999 to 2001, Dr. Ferguson was a partner at InterWest Partners focusing on life sciences investments. Prior to InterWest, he held a variety of management positions over an 11-year career at Genentech, Inc., most recently as Senior Director of Business and Corporate Development responsible for worldwide licensing transactions for both technology and pharmaceutical products. Prior to joining Genentech, Inc. in 1988, Dr. Ferguson was an associate with the law firm McCutchen, Doyle, Brown, & Enersen (currently known as Bingham McCutchen llp).

Dr. Ferguson received a B.S. with honors in Biochemistry from the University of Illinois, a Ph.D. in Biochemistry from the State University of New York at Buffalo, and a J.D. cum laude from Northwestern University. Dr. Ferguson serves on the technology advisory board of The Economist and a variety of advisory boards in the life sciences industry. In addition, he is Chairman of the Board of Anesiva, Inc. (NASDAQ:ANSV), and serves on the board of directors of several private life sciences companies.